Trifluridine and Tipiracil Oral Route

How is Trifluridine and Tipiracil Oral Route dosed?

The dosage for metastatic colorectal cancer is 35 mg of trifluridine and 26.3 mg of tipiracil per m2 of body surface area, given as a 28-day treatment cycle. The dosage for metastatic gastric or gastroesophageal junction adenocarcinoma is 50 mg of trifluridine and 40 mg of tipiracil per m2 of body surface area, also given as a 28-day treatment cycle. The dosage may vary based on individual factors and medical history. Always follow your doctor's instructions and do not adjust the dose without consulting your healthcare professional.

What is the dosage form of Trifluridine and Tipiracil Oral Route?

This medication is available in tablet form.

How is Trifluridine and Tipiracil Oral Route administered?

This medication is administered orally as a tablet. It is available only with a doctor's prescription.

What are common precautions when taking Trifluridine and Tipiracil Oral Route?

Common precautions when taking this medication include:

  1. Elderly patients should be cautious as they may be more likely to experience unwanted effects, such as blood problems.
  2. Breastfeeding mothers should consult their healthcare professional before using this medication, as there is limited information on its safety for infants.
  3. Inform your doctor about any other prescription or nonprescription medications you are taking, as interactions may require dose adjustments or additional precautions.
  4. Be aware of potential side effects, such as decreased appetite, diarrhea, hair loss, loss of strength, nausea, stomach pain, swelling or inflammation of the mouth, and vomiting. If you experience any other effects, consult your healthcare professional.